Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...

Prostate cancer usually starts to grow on the outer part of the prostate, which means it doesn't press on the tube that ...

The integration of genomic testing into cancer screening enables diagnostics to break away from conventional, one-size-fits-all protocols.

Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.

While the study found that vegetarian diets reduced the risk of five major types of cancer, it also found that vegetarian participants had nearly double the risk of squamous cell carcinoma of the ...

A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...

QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon and pancreatic cancers. New ...

Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...

I revved up my longevity protocols and sought out the latest predictive screenings. Was I seizing control of my health or ...

A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive procedure ...

Abstracts presented at ASCO GU examined whether the radioligand therapy impacts or is affected by ARPIs or chemotherapy.